CD80 and central nervous system cancer: In one recurrent glioma dataset that contained CCR7-expressing DCs, we also observed MHC-I components, stimulatory factors including IL-12B, inhibitory factors (e.g., CD274), and co-stimulatory factors (e.g., CD80) that match our murine findings (second heatmap in Figure S4E).